- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 177
Byju's takes more Tencent funding
Existing investors Tencent and General Atlantic have supplied up to $11.4m of additional funding for Byju's, which was valued at at least $3.6bn as of December.
Mar 13, 201910x goes Nationwide for series B funding
Natiowide has taken a minority stake in financial services portal developer 10x Future Technologies through a $16.9m series B investment.
Mar 12, 2019PolyAI understands $12m series A
The Cambridge spinout plans to build out the business for its automated customer support platform after collecting $12m in series A funding.
Mar 11, 2019FutureFuel powers through series A round
Salesforce and First Data participated in an $11.2m series A round that increased the total raised by the student debt repayment service to almost $16m.
Mar 11, 2019Brodmann17 counts up $11m in series A
UL and existing investors Samsung and Sony contributed to an $11m round that will fund the development of Brodmann17’s driver assistance technology.
Mar 11, 2019Corporate venturing deal net: 4-8 March 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mar 8, 2019NextHealth nabs $17m in series B round
Blue Cross of Idaho was among the investors in a series B round that took the healthcare analytics platform operator's overall funding to more than $26m
Mar 7, 2019NovaGo collects $10m
Zurich brain injury antibody spinout NovaGo has extended its strategic partnership with immunotherapy company Neurimmune by securing its support in a series A round.
Mar 6, 2019Salesforce helps Odaseva get series A serving
The data management platform has increased its overall funding to $14m in an $11.7m round featuring Salesforce Ventures and will put the cash towards recruitment.
Mar 6, 2019Stemonix stacks up series B funding
Mayo Clinic has taken part in Stemonix's $14.4m series B round, which will fund the development of additional drug screening products and services.
Mar 5, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


